Our next ACMD Challenge seminar is focused on Technological Opportunities for the Prevention of Youth Suicide. Join us on Wednesday 23 August 2023 from 2:30pm – 3:30pm AEST.
Register here: bit.ly/3OKkbBx.
For more information: bit.ly/45DkBiK
Find out about facilities to manufacture cell and tissue-based products, and bio-inks at our next ACMD Link webinar. To register: bit.ly/3rbudT7 @SVIResearch @UOW @TRICEP_AU
Distinguished Lecture Series: "New frontiers in vaccines and nanotechnology" @RMIT - join in on the hybrid event!
You are invited to attend a public lecture presented by our own @MagdalenaPleba2! She will be discussing #vaccines and how to better optimise the application therapies of them across the lifespan. Wed 21 June, hybrid event. Register here: eventbrite.com.au/e/64516003…
ACMDLink retweeted
Opportunities to work with us supporting the Medtech industry - three exciting roles open until 3 May. @UniMelb and partners are developing programs focused on training and support for the #Medtech industry in Victoria with @ACMD_BioFab.
jobs.unimelb.edu.au/caw/en/j…
ACMDLink retweeted
Join us for a special seminar next Monday 24 April:
Dr Erol Harvey, CEO of @ACMD (Aikenhead Centre for Medical Discovery), will present on how the ACMD aims to turbo-charge #MEDTECH innovation in Australia.
At 12pm - in person & on Zoom.
More info:
bit.ly/2t638Ck

ALT An image of a flyer with stylised molecular images in the background and a photo of Dr Erol Harvey in a white shirt and charcoal coloured suit jacket looking at the camera and the seminar description: Speaker icon image: Dr Erol Harvey CEO, Aikenhead Centre for Medical Discovery (ACMD) Calendar icon image: Monday 24 April, 12pm Loud speaker icon image: An introduction to ACMD
ACMDLink retweeted
Join us for our first in-person ACMD Link panel discussion on how digital health is shaping healthcare. To register: bit.ly/3Gb1get
Join us for our first in-person ACMD Link panel discussion on how digital health is shaping healthcare. To register: bit.ly/3Gb1get
#Lymphoedema is a blockage in the lymphatic system that results in the accumulation of excessive amounts of fluid. Join our next online seminar to hear more about this chronic condition - diagnosis to treatment. *Info bit.ly/3ZI7B8L
*Register - bit.ly/3Sbn3HI
Hear from
*A/Prof @LizDylke Australasian Lymphology Association
*Dr Debbie Geyer - Lymphoedema Association Australia
*Prof Neil Piller - Lymphoedema Clinical Research Unit @Flinders
*A/Prof Ramin Shayan – Plastic Surgeon, @StVincentsMelb, Director @obrieninstitute @SVIResearch
Join the discussion to hear:
-What is lymphoedema?
-How it is detected and managed?
- Possible opportunities for how technology may improve the quality of life for lymphoedema patients.
ACMDLink retweeted
For more information visit the Australasian Lymphology association (ALA) website lymphoedema.org.au or the patient association website lymphaustralia.org.au
ACMDLink retweeted
Today is lymphoedema awareness day! Lymphoedema is a type of swelling that is not uncommon but is poorly recognised. So what do you need to know about #lymphoedema ? 1) it has lots of causes! Some people have it congenitally while others develop it after damage to lymphatics
Happy to learn more about lymphoedema with ALA President @LizDylke … and cake of course
It can be difficult to progress an #innovation through from an idea to implementation in the field of health! Join the webinar to hear Prof Jill Francis locate potential sources of resistance to uptake that may help with the adoption, scaling and impact of healthcare innovations.
This Post is from an account that no longer exists. Learn more
ACMDLink retweeted
Building Australia-Germany collaborations in biomaterials to address clinical needs. Great to reconnect with colleagues in Bayreuth @unibt following our joint project supported by @studymelbourne and @veskiorg - with @LXMeagher @MonashMIME @Swinburne @UnimelbBME @CSIRO @acmd_link
Join us at ACMD Link to learn about Implementation Science on Thursday 23 Feb 2023 at 4:30PM! To register: bit.ly/3VhIzKP @UniMelbMDHS
ACMDLink retweeted
Listening to this before I facilitate the workshop next week. 15000 people are diagnosed with bowel cancer in Australia annually, 5000 die every year from bowel cancer. It's the 2nd deadliest cancer for all people.
Bowel cancer claims more lives than breast or prostate cancer. Join our next seminar to hear from Stephanie Bansemer-Brown @BowelCancerAust, John Ding, Gastroenterologist @IBD_JohnD, Christina Trambas, Bree James Senior Scientist @StVincentsMelb
Info -> bit.ly/3RgF9rA
ACMDLink retweeted
Hopefully we can decrease the stigma with bowel cancer and move the field forward with better patient involvement and improved screening programs #bowelcancer #bowelcancerscreening @ACMD_BioFab
Bowel cancer claims more lives than breast or prostate cancer. Join our next seminar to hear from Stephanie Bansemer-Brown @BowelCancerAust, John Ding, Gastroenterologist @IBD_JohnD, Christina Trambas, Bree James Senior Scientist @StVincentsMelb
Info -> bit.ly/3RgF9rA
ACMDLink retweeted
Looking forward to this session - bowel cancer is Australia’s second deadliest cancer, it’s 99% treatable if caught early…BUT screening rates lag…we need to change behaviour!
Bowel cancer claims more lives than breast or prostate cancer. Join our next seminar to hear from Stephanie Bansemer-Brown @BowelCancerAust, John Ding, Gastroenterologist @IBD_JohnD, Christina Trambas, Bree James Senior Scientist @StVincentsMelb
Info -> bit.ly/3RgF9rA
Bowel cancer claims more lives than breast or prostate cancer. Join our next seminar to hear from Stephanie Bansemer-Brown @BowelCancerAust, John Ding, Gastroenterologist @IBD_JohnD, Christina Trambas, Bree James Senior Scientist @StVincentsMelb
Info -> bit.ly/3RgF9rA
1/3 Thank you to the speakers and session chairs of ACMD Link 2022 for your interesting talks and discussions.
2/3 @dcapurro ErolHarvey GeraldineMitchell LeonDunn RobKapsa SanjeevGambhir ThomasEdwards VictoriaMcLeod @StVincentsMelb @unimelb @SVIResearch @UOW @BionicsInst @GenesisCare @EyeResearchAus @RMIT @Swinburne





















